Antipsychotic-Induced Movement Disorder

Screening via Telemental Health

Jay Shore, Alexander Vo, Peter Yellowlees, Maryann Waugh, Christopher Schneck, Herbert Nagamoto, Marshall Thomas

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The purpose of this brief report is to make clinical and research recommendations to advance current knowledge and practices related to the assessment of antipsychotic drug-induced movement disorders (DIMDs) via live interactive videoconferencing. Materials and Methods: The authors provide an overview of the frequent neurological side effects of antipsychotic drugs and review relevant telemedicine research. DIMD prevention is critical, but these disorders remain underdetected and under-reported. Although there are not yet formal recommendations for specific screening tools or screening frequency, baseline and annual assessments are generally agreed-upon minimums. As DIMD awareness increases and more specific guidelines are developed to steer assessments, telemental health may aid practitioners in efficiently and regularly monitoring onset and severity. Research shows that videoconferencing can be used for effective psychiatric treatments and assessment, with at least one study validating the use of videoconference assessment for a subset of movement disorders. Results and Conclusions: Clinical recommendations include developing practice-level protocols and procedures that include regular DIMD assessment (either in-person or via telemedicine) for the full spectrum of possible movement disorders for all patients taking antipsychotic medications. Research and evaluation recommendations include replicating and expanding upon the existing study using videoconferencing to assess movement disorder symptoms, using asynchronous telemental health assessments of DIMDs, and pilot-testing facial and movement recognition software to allow for clinical comparison of patients' movement patterns over time.

Original languageEnglish (US)
Pages (from-to)1027-1029
Number of pages3
JournalTelemedicine and e-Health
Volume21
Issue number12
DOIs
StatePublished - Dec 1 2015
Externally publishedYes

Fingerprint

Movement Disorders
Antipsychotic Agents
Videoconferencing
Health
Telemedicine
Pharmaceutical Preparations
Research
Drug-Related Side Effects and Adverse Reactions
Psychiatry
Software
Guidelines

Keywords

  • Drug-induced movement disorder antipsychotics
  • Movement disorders
  • Psychiatry
  • Telehealth
  • Telemedicine
  • Telemental health

ASJC Scopus subject areas

  • Medicine(all)
  • Health Informatics
  • Health Information Management

Cite this

Shore, J., Vo, A., Yellowlees, P., Waugh, M., Schneck, C., Nagamoto, H., & Thomas, M. (2015). Antipsychotic-Induced Movement Disorder: Screening via Telemental Health. Telemedicine and e-Health, 21(12), 1027-1029. https://doi.org/10.1089/tmj.2014.0242

Antipsychotic-Induced Movement Disorder : Screening via Telemental Health. / Shore, Jay; Vo, Alexander; Yellowlees, Peter; Waugh, Maryann; Schneck, Christopher; Nagamoto, Herbert; Thomas, Marshall.

In: Telemedicine and e-Health, Vol. 21, No. 12, 01.12.2015, p. 1027-1029.

Research output: Contribution to journalArticle

Shore, J, Vo, A, Yellowlees, P, Waugh, M, Schneck, C, Nagamoto, H & Thomas, M 2015, 'Antipsychotic-Induced Movement Disorder: Screening via Telemental Health', Telemedicine and e-Health, vol. 21, no. 12, pp. 1027-1029. https://doi.org/10.1089/tmj.2014.0242
Shore J, Vo A, Yellowlees P, Waugh M, Schneck C, Nagamoto H et al. Antipsychotic-Induced Movement Disorder: Screening via Telemental Health. Telemedicine and e-Health. 2015 Dec 1;21(12):1027-1029. https://doi.org/10.1089/tmj.2014.0242
Shore, Jay ; Vo, Alexander ; Yellowlees, Peter ; Waugh, Maryann ; Schneck, Christopher ; Nagamoto, Herbert ; Thomas, Marshall. / Antipsychotic-Induced Movement Disorder : Screening via Telemental Health. In: Telemedicine and e-Health. 2015 ; Vol. 21, No. 12. pp. 1027-1029.
@article{ef1b52f646ea4c7a860915428fc8e3cd,
title = "Antipsychotic-Induced Movement Disorder: Screening via Telemental Health",
abstract = "Background: The purpose of this brief report is to make clinical and research recommendations to advance current knowledge and practices related to the assessment of antipsychotic drug-induced movement disorders (DIMDs) via live interactive videoconferencing. Materials and Methods: The authors provide an overview of the frequent neurological side effects of antipsychotic drugs and review relevant telemedicine research. DIMD prevention is critical, but these disorders remain underdetected and under-reported. Although there are not yet formal recommendations for specific screening tools or screening frequency, baseline and annual assessments are generally agreed-upon minimums. As DIMD awareness increases and more specific guidelines are developed to steer assessments, telemental health may aid practitioners in efficiently and regularly monitoring onset and severity. Research shows that videoconferencing can be used for effective psychiatric treatments and assessment, with at least one study validating the use of videoconference assessment for a subset of movement disorders. Results and Conclusions: Clinical recommendations include developing practice-level protocols and procedures that include regular DIMD assessment (either in-person or via telemedicine) for the full spectrum of possible movement disorders for all patients taking antipsychotic medications. Research and evaluation recommendations include replicating and expanding upon the existing study using videoconferencing to assess movement disorder symptoms, using asynchronous telemental health assessments of DIMDs, and pilot-testing facial and movement recognition software to allow for clinical comparison of patients' movement patterns over time.",
keywords = "Drug-induced movement disorder antipsychotics, Movement disorders, Psychiatry, Telehealth, Telemedicine, Telemental health",
author = "Jay Shore and Alexander Vo and Peter Yellowlees and Maryann Waugh and Christopher Schneck and Herbert Nagamoto and Marshall Thomas",
year = "2015",
month = "12",
day = "1",
doi = "10.1089/tmj.2014.0242",
language = "English (US)",
volume = "21",
pages = "1027--1029",
journal = "Telemedicine and e-Health",
issn = "1530-5627",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - Antipsychotic-Induced Movement Disorder

T2 - Screening via Telemental Health

AU - Shore, Jay

AU - Vo, Alexander

AU - Yellowlees, Peter

AU - Waugh, Maryann

AU - Schneck, Christopher

AU - Nagamoto, Herbert

AU - Thomas, Marshall

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Background: The purpose of this brief report is to make clinical and research recommendations to advance current knowledge and practices related to the assessment of antipsychotic drug-induced movement disorders (DIMDs) via live interactive videoconferencing. Materials and Methods: The authors provide an overview of the frequent neurological side effects of antipsychotic drugs and review relevant telemedicine research. DIMD prevention is critical, but these disorders remain underdetected and under-reported. Although there are not yet formal recommendations for specific screening tools or screening frequency, baseline and annual assessments are generally agreed-upon minimums. As DIMD awareness increases and more specific guidelines are developed to steer assessments, telemental health may aid practitioners in efficiently and regularly monitoring onset and severity. Research shows that videoconferencing can be used for effective psychiatric treatments and assessment, with at least one study validating the use of videoconference assessment for a subset of movement disorders. Results and Conclusions: Clinical recommendations include developing practice-level protocols and procedures that include regular DIMD assessment (either in-person or via telemedicine) for the full spectrum of possible movement disorders for all patients taking antipsychotic medications. Research and evaluation recommendations include replicating and expanding upon the existing study using videoconferencing to assess movement disorder symptoms, using asynchronous telemental health assessments of DIMDs, and pilot-testing facial and movement recognition software to allow for clinical comparison of patients' movement patterns over time.

AB - Background: The purpose of this brief report is to make clinical and research recommendations to advance current knowledge and practices related to the assessment of antipsychotic drug-induced movement disorders (DIMDs) via live interactive videoconferencing. Materials and Methods: The authors provide an overview of the frequent neurological side effects of antipsychotic drugs and review relevant telemedicine research. DIMD prevention is critical, but these disorders remain underdetected and under-reported. Although there are not yet formal recommendations for specific screening tools or screening frequency, baseline and annual assessments are generally agreed-upon minimums. As DIMD awareness increases and more specific guidelines are developed to steer assessments, telemental health may aid practitioners in efficiently and regularly monitoring onset and severity. Research shows that videoconferencing can be used for effective psychiatric treatments and assessment, with at least one study validating the use of videoconference assessment for a subset of movement disorders. Results and Conclusions: Clinical recommendations include developing practice-level protocols and procedures that include regular DIMD assessment (either in-person or via telemedicine) for the full spectrum of possible movement disorders for all patients taking antipsychotic medications. Research and evaluation recommendations include replicating and expanding upon the existing study using videoconferencing to assess movement disorder symptoms, using asynchronous telemental health assessments of DIMDs, and pilot-testing facial and movement recognition software to allow for clinical comparison of patients' movement patterns over time.

KW - Drug-induced movement disorder antipsychotics

KW - Movement disorders

KW - Psychiatry

KW - Telehealth

KW - Telemedicine

KW - Telemental health

UR - http://www.scopus.com/inward/record.url?scp=84948744457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948744457&partnerID=8YFLogxK

U2 - 10.1089/tmj.2014.0242

DO - 10.1089/tmj.2014.0242

M3 - Article

VL - 21

SP - 1027

EP - 1029

JO - Telemedicine and e-Health

JF - Telemedicine and e-Health

SN - 1530-5627

IS - 12

ER -